Atlas Trials

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC

Clinical trial NCT04182698 · UNKNOWN

Trial details

NCT number
NCT04182698
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Patients With Non-small Cell Lung Cancer
Start date
2019-11-22
Primary completion
2021-05-17
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.